Want to see VRTX full AI Analyst Report?
Vertex Pharmaceuticals (VRTX) Q4 2020 Earnings Report
VRTX Q4 2020 EPS Results
- Actual EPS
- $2.51
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- $1.70
VRTX Q4 2020 Revenue Results
- Actual Revenue
- $1.64B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +16.60%
Earnings Announcement Details
- Quarter
- Q4 2020
- Date
- 02/01/2021
- Time
- After Close
- Conference Call
- Monday, February 1, 2021
VRTX Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q4 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
VRTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | 4.73- | 5.03 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 4.824.76 | 4.8 | -0.83% (-0.04) | |
| Aug 03, 2026 | 2026 (Q2) | 4.744.73 | 4.52 | 4.65% (+0.21) | |
| May 04, 2026 | 2026 (Q1) | 4.244.47 | 4.06 | 10.10% (+0.41) | |
| Feb 12, 2026 | 2025 (Q4) | 5.115.03 | 3.98 | 26.38% (+1.05) | |
| Nov 03, 2025 | 2025 (Q3) | 4.574.80 | 4.38 | 9.59% (+0.42) | |
| Aug 06, 2025 | 2025 (Q2) | 4.294.52 | -12.83 | 135.23% (+17.35) | |
| May 05, 2025 | 2025 (Q1) | 4.324.06 | 4.76 | -14.71% (-0.70) | |
| Feb 10, 2025 | 2024 (Q4) | 4.023.98 | 4.2 | -5.24% (-0.22) | |
| Nov 04, 2024 | 2024 (Q3) | 4.084.38 | 4.08 | 7.35% (+0.30) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
